These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 20428949)

  • 1. Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipation.
    Sloots CE; Rykx A; Cools M; Kerstens R; De Pauw M
    Dig Dis Sci; 2010 Oct; 55(10):2912-21. PubMed ID: 20428949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives.
    Tack J; van Outryve M; Beyens G; Kerstens R; Vandeplassche L
    Gut; 2009 Mar; 58(3):357-65. PubMed ID: 18987031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A placebo-controlled trial of prucalopride for severe chronic constipation.
    Camilleri M; Kerstens R; Rykx A; Vandeplassche L
    N Engl J Med; 2008 May; 358(22):2344-54. PubMed ID: 18509121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study.
    Quigley EM; Vandeplassche L; Kerstens R; Ausma J
    Aliment Pharmacol Ther; 2009 Feb; 29(3):315-28. PubMed ID: 19035970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation.
    Yiannakou Y; Piessevaux H; Bouchoucha M; Schiefke I; Filip R; Gabalec L; Dina I; Stephenson D; Kerstens R; Etherson K; Levine A
    Am J Gastroenterol; 2015 May; 110(5):741-8. PubMed ID: 25869393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between health-related quality of life and symptoms in patients with chronic constipation: an integrated analysis of three phase 3 trials of prucalopride.
    Tack J; Camilleri M; Dubois D; Vandeplassche L; Joseph A; Kerstens R
    Neurogastroenterol Motil; 2015 Mar; 27(3):397-405. PubMed ID: 25581251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of prucalopride in patients with constipation due to spinal cord injury.
    Krogh K; Jensen MB; Gandrup P; Laurberg S; Nilsson J; Kerstens R; De Pauw M
    Scand J Gastroenterol; 2002 Apr; 37(4):431-6. PubMed ID: 11989834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety analysis of prucalopride in refractory chronic constipation cases in a tertiary care hospital in Eastern India: A randomized, single-blind, placebo-controlled study.
    Dehury S; Mohapatra S; Das HS; Goutam S; Kaushik C
    Indian J Pharmacol; 2023; 55(1):6-13. PubMed ID: 36960515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised clinical trial: macrogol/PEG 3350+electrolytes versus prucalopride in the treatment of chronic constipation -- a comparison in a controlled environment.
    Cinca R; Chera D; Gruss HJ; Halphen M
    Aliment Pharmacol Ther; 2013 May; 37(9):876-86. PubMed ID: 23480216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized study of lubiprostone for opioid-induced constipation in patients with chronic noncancer pain.
    Cryer B; Katz S; Vallejo R; Popescu A; Ueno R
    Pain Med; 2014 Nov; 15(11):1825-34. PubMed ID: 24716835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prucalopride on symptoms of chronic constipation.
    Tack J; Stanghellini V; Dubois D; Joseph A; Vandeplassche L; Kerstens R
    Neurogastroenterol Motil; 2014 Jan; 26(1):21-7. PubMed ID: 24106924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prucalopride is effective in patients with severe chronic constipation in whom laxatives fail to provide adequate relief. Results of a double-blind, placebo-controlled clinical trial.
    Coremans G; Kerstens R; De Pauw M; Stevens M
    Digestion; 2003; 67(1-2):82-9. PubMed ID: 12743445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled study.
    Camilleri M; Beyens G; Kerstens R; Robinson P; Vandeplassche L
    Neurogastroenterol Motil; 2009 Dec; 21(12):1256-e117. PubMed ID: 19751247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study.
    Ke M; Zou D; Yuan Y; Li Y; Lin L; Hao J; Hou X; Kim HJ
    Neurogastroenterol Motil; 2012 Nov; 24(11):999-e541. PubMed ID: 22882724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prucalopride.
    Frampton JE
    Drugs; 2009; 69(17):2463-76. PubMed ID: 19911858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of oral prucalopride in women with chronic constipation in whom laxatives have failed: an integrated analysis.
    Tack J; Quigley E; Camilleri M; Vandeplassche L; Kerstens R
    United European Gastroenterol J; 2013 Feb; 1(1):48-59. PubMed ID: 24917940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prucalopride: a review of its use in the management of chronic constipation.
    Keating GM
    Drugs; 2013 Nov; 73(17):1935-50. PubMed ID: 24194435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation.
    Sloots CE; Poen AC; Kerstens R; Stevens M; De Pauw M; Van Oene JC; Meuwissen SG; Felt-Bersma RJ
    Aliment Pharmacol Ther; 2002 Apr; 16(4):759-67. PubMed ID: 11929394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase 2b, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain.
    Webster LR; Yamada T; Arjona Ferreira JC
    Pain Med; 2017 Dec; 18(12):2350-2360. PubMed ID: 28371937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prucalopride is no more effective than placebo for children with functional constipation.
    Mugie SM; Korczowski B; Bodi P; Green A; Kerstens R; Ausma J; Ruth M; Levine A; Benninga MA
    Gastroenterology; 2014 Dec; 147(6):1285-95.e1. PubMed ID: 25239590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.